We are BrainsWay

What BrainsWay is all about

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain four FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy.

Current indications include major depressive disorder, obsessive-compulsive disorder, smoking addiction, and anxious depression. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA, Cresskill, NJ and Jerusalem, Israel, BrainsWay is committed to increasing global awareness and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit the news page.

Our Leadership Team

Christopher von Jako

Christopher R. von Jako, PhD

President and Chief Executive Officer (CEO)

Scott Areglado, Senior VP and Chief Financial Officer (CFO)

Scott Areglado

Senior VP and Chief Financial Officer (CFO)

Hadar Levy - Chief Financial Officer at BrainsWay

Hadar Levy

Senior VP and GM of North America

Moria Ankry

Moria Ankry

VP of Research & Development

Chris Boyer

Christopher Boyer

VP of Global Marketing

Amit Ginou - VP of Field & Clinical Operations at BrainsWay

Amit Ginou

VP and Site Manager

Fran Hackett VP of North America Sales

Fran Hackett

VP of North America Sales

Menachem C. Klein, Esq. VP, General Counsel and Corporate Secretary

Menachem C. Klein, Esq.

VP, General Counsel and Corporate Secretary

Yiftach Roth, PhD - Founder of BrainsWay

Yiftach Roth, PhD

Chief Scientific Officer (CSO)

Aron Tendler MD

Aron Tendler, MD, C.BSM

Chief Medical Officer (CMO)

David Zacut - Director at BrainsWay

David Zacut, MD

Chairman of the Board

Yossi Ben Shalom

Yossi Ben Shalom

Board Director

Avner Hagai - Director at BrainsWay

Avner Hagai

Board Director

Avner Lushi

Avner Lushi

Board Director

Eti Mitrany - Director at BrainsWay

Eti Mitrany

Board Director

Karen Sarid - Director at BrainsWay

Karen Sarid

Board Director

Avraham Zangen, PhD - Sits on the Scientific Advisory Board at BrainsWay

Abraham Zangen, PhD

Board Director

Avner Hagai - Director at BrainsWay

Avner Hagai

Board Director

Yiftach Roth, PhD - Founder of BrainsWay

Yiftach Roth, PhD

Chief Scientific Officer (CSO)

David Zacut - Director at BrainsWay

David Zacut, MD

Chairman of the Board

Avraham Zangen, PhD - Sits on the Scientific Advisory Board at BrainsWay

Abraham Zangen, PhD

Board Director

Join Us

A career with BrainsWay is more than just a job. It’s personal. As a leader in non-invasive brain stimulation we’re deeply committed to help patients who suffer from brain disorders. If you’re a natural problem-solver with the imagination, courage and spirit to make a meaningful difference, BrainsWay is where you want to build your career.

Current Open Positions

    News & Events

    See all the latest news, events and in the media BrainsWay has to offer, and everything in-between.

    November 17, 2021

    BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights

    Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System...

    November 3, 2021

    BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021

    BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

    October 12, 2021

    BrainsWay Announces Prominent Addition to Scientific Advisory Board

    Zafiris Daskalakis, MD, PhD to Bring Extensive Research and Clinical Expertise to Assist in Guiding Growth...